Blue Trust’s Prothena PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$277 Hold
33
– – ﹤0.01% 2343
2026
Q2
$323 Hold
33
– – ﹤0.01% 2374
2026
Q1
$321 Hold
33
– – ﹤0.01% 2384
2025
Q4
$315 Hold
33
– – ﹤0.01% 2453
2025
Q3
$322 Hold
33
– – ﹤0.01% 2477
2025
Q2
$200 Sell
33
-678
-95% -$5.09K ﹤0.01% 2381
2025
Q1
$8.8K Hold
711
– – ﹤0.01% 1947
2024
Q4
$9.8K Buy
711
+658
+1,242% +$10.4K ﹤0.01% 1905
2024
Q3
$1.09K Sell
53
-117
-69% -$2.52K ﹤0.01% 2690
2024
Q2
$4.21K Buy
+170
New +$3.68K ﹤0.01% 2256

Other funds holding PRTA

Blue Trust's PRTA Position: Q3 2026 in Review

Blue Trust held its Prothena (PRTA) position steady in Q3 2026 at 33 shares worth $277. The position accounts for ﹤0.01% of the portfolio, ranked #2343.

Blue Trust first reported a position in PRTA in Q2 2024 and has held it in 10 quarters since. The position peaked at $9.8K in Q4 2024. 133 funds tracked by Wall St. Rank hold PRTA as of Q3 2026.

  • Blue Trust held 33 shares of Prothena worth $277 as of Q3 2026.
  • Blue Trust left its Prothena share count unchanged in Q3 2026.
  • Prothena made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2343 holding.
  • Blue Trust first reported a position in Prothena in Q2 2024 and has held it in 10 quarters since.
  • Blue Trust's Prothena position peaked at $9.8K in Q4 2024.
  • 133 funds tracked by Wall St. Rank held Prothena as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.